HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Tuesday reported profit of $4 million in its third quarter. On a per-share basis, the Hackensack, New Jersey-based company said it had net income of 5 cents. The drug developer posted revenue of $21.9 million in the period. Protalix expects full-year revenue...